Dr. Willis is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
The University of Texas MD Anderson Cancer Center
1515 Holcombe Blvd., Unit 0426
Houston, TX 77030
Summary
- Dr. Jason Willis is an oncologist in Houston, TX and is affiliated with multiple hospitals in the area, including University of Texas M.D. Anderson Cancer Center and Harris Health System. He received his medical degree from Weill Cornell Medicine and has been in practice 2 years. He specializes in cancer genetics/cancer risk assessment and gastrointestinal cancer and is experienced in pancreatic cancer.
Education & Training
University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Hematology and Medical Oncology, 2016 - 2019
Johns Hopkins UniversityResidency, Internal Medicine, 2014 - 2017
Weill Cornell MedicineClass of 2014, M.D.
Certifications & Licensure
FL State Medical License 2021 - Present
TX State Medical License 2018 - 2026
MS State Medical License 2023 - 2025
TN State Medical License 2023 - 2025
WA State Medical License 2023 - 2025
AL State Medical License 2023 - 2024- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Phase 1b Study to Evaluate ATP128, VSV-GP128 and BI 754091, in Patients With Stage IV Colorectal Cancer Start of enrollment: 2019 Jul 22
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- 2 citationsAddition of Metastasis-Directed Therapy to Systemic Therapy for Oligometastatic Pancreatic Ductal Adenocarcinoma (EXTEND): A Multicenter, Randomized Phase II Trial.Ethan B Ludmir, Alexander D Sherry, Bryan M Fellman, Suyu Liu, Tharakeswara Bathala
Journal of Clinical Oncology. 2024-11-10 - 1 citationsMolecular, Socioeconomic, and Clinical Factors Affecting Racial and Ethnic Disparities in Colorectal Cancer Survival.Mahmoud Yousef, Abdelrahman Yousef, Saikat Chowdhury, Mohammad M Fanaeian, Mark Knafl
JAMA Oncology. 2024-11-01 - Molecular and Clinical Features of Pancreatic Acinar Cell Carcinoma: A Single-Institution Case Series.Ashwathy Balachandran Pillai, Mahmoud Yousef, Abdelrahman Yousef, Kristin D Alfaro-Munoz, Brandon G Smaglo
Cancers. 2024-10-09
Journal Articles
- Colorectal Premalignancy Is Associated with Consensus Molecular Subtypes 1 and 2L M Ellis, P M Lynch, J A Willis, S Kopetz, Annals of Oncology
Press Mentions
Breaking Barriers to Colorectal Cancer Care for Black PatientsNovember 7th, 2023- ‘It’s Striking’: MD Anderson Researcher Investigates Cause of Racial Disparities in Colon CancerMarch 5th, 2022
- Breaking Barriers to Colorectal Cancer Care for Black PatientsNovember 10th, 2023
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
